Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sanofi - American Depositary Shares (NQ:SNY)

46.77 -0.62 (-1.30%)
Streaming Delayed Price Updated: 3:34 PM EST, Feb 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Sanofi - American Depositary Shares

< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
40 41 Next >
News headline image
Elon Musk-Backed Neuralink Starts Participant Enrollment For Paralysis, Eli Lilly Cracks Down on Counterfeit Weight Loss Drugs, Meta Looks to Capitalize on India's In-App Payment Surge: Today's Top Stories ↗
Benzinga 
Via Benzinga
News headline image
FDA Rejects EpiPen Alternative - ARS Pharmaceuticals' Allergic Reaction Nasal Spray ↗
The FDA issued a Complete Response Letter regarding ARS Pharmaceuticals Inc's (NASDAQ: SPRY) New Drug Application (NDA) for neffy (epinephrine nasal spray) in the treatment of Allergic Reactions (Type... 
Via Benzinga
News headline image
3 Stocks to Buy to Ride Europe’s Coming Market Surge ↗
With Europe’s markets looking to perform better in the second half of 2023, here are three European stocks to buy to ride the wave. 
Via InvestorPlace
News headline image
Looking Into Sanofi's Recent Short Interest ↗
 
Via Benzinga
News headline image
(SNY) - Analyzing Sanofi's Short Interest ↗
 
Via Benzinga
News headline image
2 Top Biotech Stocks to Buy Right Now ↗
These drugmakers are among the most dominant in the world. 
Via The Motley Fool
News headline image
Why Shares of MacroGenics Are Jumping Thursday ↗
The company announced second-quarter earnings. 
Via The Motley Fool
News headline image
Moderna's R&D Day Unveils Strategic Roadmap Beyond COVID Franchise: Goldman Sachs ↗
On Wednesday, Moderna Inc (NASDAQ: MRNA) conducted an R&D Day event outlining its strategic initiatives across four key areas - Respiratory Vaccines, Latent/Other Vaccines, Oncology Therapeutics,  
Via Benzinga
News headline image
This Market Could Be Worth $10 Billion by 2030 -- 2 Stocks to Buy Now ↗
This market is currently in its infancy. 
Via The Motley Fool
News headline image
'Transformative Event' For First Wave BioPharma: License Agreement for Hopeful Gastrointestinal Candidate From Sanofi ↗
First Wave BioPharma Inc (NASDAQ: FWBI) announced an agreement with Sanofi SA (NASDAQ: SNY) to license Capeserod, a selective 5-HT4 receptor partial agonist, which First Wave will repurpose and develop... 
Via Benzinga
News headline image
Flu Vaccine Results Give Moderna (MRNA) Stock a Shot in the Arm ↗
Moderna released encouraging results for its late-stage trial of its flu vaccine. Now, MRNA stock is looking like more than a one-trick pony. 
Via InvestorPlace
News headline image
Moderna Stock Has Been Beaten Up; Why The CFO Says Its Story Is 'Misunderstood' ↗
Moderna unveiled promising results in flu on Wednesday, adding to its respiratory suite. 
Via Investor's Business Daily
News headline image
Looking Into Sanofi's Recent Short Interest ↗
 
Via Benzinga
News headline image
The Top Healthcare Stocks to Buy With $100 ↗
There's no need to have a fortune to invest in stocks. 
Via The Motley Fool
News headline image
Sanofi (SNY) Q2 2023 Earnings Call Transcript ↗
SNY earnings call for the period ending June 30, 2023. 
Via The Motley Fool
News headline image
Could This Medicine Be the Next Winner for Novartis? ↗
The Swiss drugmaker recently reported that a drug candidate met the primary endpoints in phase 3 clinical trials. 
Via The Motley Fool
News headline image
FDA Greenlights Pfizer's RSV Vaccine: Moms Can Now Protect Babies Before Birth ↗
Monday, the FDA approved Pfizer Inc's (NYSE: PFE) Abrysvo (Respiratory Syncytial Virus Vaccine), the company's bivalent RSV prefusion F (RSVpreF) vaccine, to prevent the infection in infants from birth... 
Via Benzinga
News headline image
Is Regeneron Pharmaceuticals Still a Top Growth Stock? ↗
The biotech's focus on innovation could be a boon for shareholders. 
Via The Motley Fool
News headline image
2 Biotech Stocks That Could Make You Richer ↗
Neither is performing particularly well this year compared to the broader market, but don't let that chase you away. 
Via The Motley Fool
News headline image
Amazon's Boon for Diabetes Patients - Streamlining Pharmacy Discounts ↗
Amazon.Com Inc's (NASDAQ: AMZN) online pharmacy launched a new initiativ 
Via Benzinga
News headline image
Sanofi's Earnings Outlook ↗
 
Via Benzinga
News headline image
As Tiziana Life Sciences (NASDAQ: TLSA) Prepares For Phase 2 Trials, Have They Successfully Derisked Foralumab? ↗
Tiziana Life Sciences, Inc. 
Via Benzinga
News headline image
Tiziana (NASDAQ: TLSA) Continues The Fight Against Multiple Sclerosis, Will Announce 6-Month Results For Its Novel Treatment Soon ↗
Tiziana Life Sciences (NASDAQ: TLSA), a clinical-stage biotechnology company focused on developing immunotherapies, will soon announce the 6-month results for patients with non-active Secondary... 
Via Benzinga
News headline image
Here are 3 AI Drug Discovery Stocks to Put on Your Watchlist
Artificial intelligence (AI) has hit the mainstream with fervor. Specifically, generative AI has gone viral with the explosion in ChatGPT users. 
Via MarketBeat
Topics Artificial Intelligence
News headline image
iPhone US Shipments Take A Hit, Does Social Media Algorithm Impact Political Beliefs? Research Reveals Answer, Disney Joins Netflix To Crack Down Password Sharing In India: Today's Top Stories ↗
Bloomberg 
Via Benzinga
News headline image
Sanofi Reports Lower Q2 Earnings, But Lifts 2023 Outlook On New Drug Launches ↗
Sanofi SA (NASDAQ: SNY) reported a 1% decline in Q2 business operating in 
Via Benzinga
News headline image
US Stock Futures Signal Rebound On Tech Earnings Support: Analyst Tells Why Fed May Not Start Cutting Rates Anytime Soon ↗
Stocks appear to have shaken off Thursday's negativity and are positioned for a rebound on upbeat earnings. 
Via Benzinga
News headline image
Enphase Energy, Sanofi, Ford And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
U.S. stock futures traded higher this morning on Friday. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
News headline image
Exscientia is the Sniper of the AI Drug Discovery Industry
News of a $50 million investment by artificial intelligence (AI) leader Nvidia Co. (Nasdaq: NVDA) into AI-powered drug discovery company Recursion 
Via MarketBeat
Topics Artificial Intelligence
News headline image
Earnings Scheduled For July 28, 2023 ↗
Companies Reporting Before The Bell • Sanofi (NASDAQ:SNY) is likely to report quarterly earnings at $1.58 per share on revenue of $11.32 billion. 
Via Benzinga
< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
40 41 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.